UnitedHealth Group stock: At EUR 371.20, UnitedHealth Group stock gains 3.51 percent
Published on 10/20/2026 at 16:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSPrice move and analyst target
- UnitedHealth Group stock stood 3.51 percent above the Xetra close on October 20, 2026.
- JPMorgan's target reached USD 524 from USD 516 on October 16, 2026.
- UnitedHealth Group stock costs EUR 371.20 at Lang & Schwarz on October 20, 2026 at 4:08 p.m. CEST, 3.51 percent above the Xetra close of October 19, 2026.
UnitedHealth Group (ISIN US91324P1021) stock stood 3.51 percent above the Xetra close on October 20, 2026. JPMorgan raised its price target from USD 516 to USD 524 on October 16, 2026, according to Markets Insider. At Lang & Schwarz, the stock was trading at EUR 371.20 on October 20, 2026 at 4:08 p.m. CEST, up 3.51 percent versus the Xetra close of October 19, 2026.
JPMorgan target reaches USD 524
The JPMorgan target is 25.77 percent above the NYSE price of USD 416.64 at 10:20 a.m. EDT on October 20, 2026. The comparison uses the same currency on both sides, while the euro quote remains the price used for German investors.
JPMorgan's move followed UnitedHealth's third-quarter reporting period, but the target itself is the relevant analyst signal for this market report. The note kept an Overweight rating, according to Markets Insider.
Stock stays below its yearly high
The euro quote is 7.34 percent below the 52-week high of EUR 400.60 and above the 52-week low of EUR 222.70. The range and the EUR 332.1 billion market capitalization are as of October 20, 2026, giving the daily move a wider valuation frame.
What does the target imply?
The counter-factor is valuation and regulatory uncertainty. On October 15, Raymond James cut its target from USD 475 to USD 450 while retaining an Outperform rating, citing concerns about midterm elections and possible changes to risk adjustment and Stars, as Investing.com reported.
UnitedHealth identifies the security as NYSE: UNH in its October 13, 2026 results release, which also places the company in the managed healthcare industry, according to UnitedHealth Group. For investors, the key distinction is clear: JPMorgan's USD 524 target points higher, while Raymond James' USD 450 target shows that analyst views remain materially separated.
Euro quote and valuation frame
UnitedHealth Group was trading at EUR 371.20 at Lang & Schwarz on October 20, 2026 at 4:08 p.m. CEST, up 3.51 percent versus the Xetra close of October 19, 2026. Its price-to-earnings ratio was 23.74 as of October 20, 2026, alongside a trailing dividend yield of 2.00 percent.
The further course of trading is shown by the continuously updated real-time quote of UnitedHealth Group stock.
UnitedHealth Group stock at a glance
- Company: UnitedHealth Group Incorporated
- ISIN: US91324P1021
- Ticker: UNH
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 20, 2026, 4:08 p.m. CEST): EUR 371.20
- Change versus Xetra close: plus 3.51 percent
- Xetra close (October 19, 2026): EUR 358.60
- Market capitalization: EUR 332.1 billion (as of October 20, 2026)
- 52-week range: EUR 222.70-400.60 (as of October 20, 2026)
- Sector / Industry: Healthcare / Medical - Healthcare Plans
Market context: Market report S&P 500.
